Literature DB >> 10356154

Hepatic veno-occlusive disease in ataxia-telangiectasia.

N Srisirirojanakorn1, M J Finegold, G S Gopalakrishna, W J Klish.   

Abstract

Existing descriptions of liver abnormalities in ataxia-telangiectasia have been associated with co-existent hepatitis virus infection. Here we report veno-occlusive disease of the liver in 2 patients with ataxia telangiectasia that is not attributable to bone marrow transplantation or coincidental hepatitis infection.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10356154     DOI： 10.1016/s0022-3476(99)70301-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  4 in total

1.  Allogeneic-matched sibling stem cell transplantation in a 13-year-old boy with ataxia telangiectasia and EBV-positive non-Hodgkin lymphoma.

Authors:  R Beier; K-W Sykora; W Woessmann; B Maecker-Kolhoff; M Sauer; H H Kreipe; T Dörk-Bousset; C Kratz; M Lauten
Journal:  Bone Marrow Transplant       Date:  2016-05-09       Impact factor: 5.483

2.  Vesical varices and telangiectasias in a patient with ataxia telangiectasia.

Authors:  Koichi Suzuki; Koji Tsugawa; Eishin Oki; Tomohiro Morio; Etsuro Ito; Hiroshi Tanaka
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

3.  Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia.

Authors:  Sujal Ghosh; Friedhelm R Schuster; Vera Binder; Tim Niehues; Stephan E Baldus; Peter Seiffert; Hans-Jürgen Laws; Arndt Borkhardt; Roland Meisel
Journal:  J Clin Immunol       Date:  2012-02-23       Impact factor: 8.542

4.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.